Dr. Jothydev Kesavadev spoke at ATTD Asia on the evolving links between obesity, fatty liver disease (MASLD/MASH) and diabetes, highlighting the importance of early screening and personalised metabolic therapy. This was complemented by presentations from Dr. Arun Shankar and Anjana Basanth, who shared original research from Jothydev’s Diabetes & Research Centre demonstrating the benefits of structured, telemedicine-aided semaglutide titration and the growing role of virtual care in optimising long-term diabetes outcomes.